eYantra Ventures reports FY26 results, consolidated loss widens
eYantra Ventures Limited reported a standalone net profit of ₹26.53 lakh for FY26, while consolidated net loss widened to ₹475.05 lakh. Total income increased to ₹9,469.42 lakh in consolidated results, driven by segments like merchandise and hospital services. The company invested ₹1,080 lakh in an associate company and utilized preferential issue proceeds for business opportunities.

*this image is generated using AI for illustrative purposes only.
eYantra Ventures Limited reported a standalone net profit of ₹26.53 lakh for the financial year ended March 31, 2026, while its consolidated financial results reflected a net loss of ₹475.05 lakh for the same period. The Board of Directors approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, at a meeting held on May 25, 2026. The statutory auditor issued an unmodified opinion on the financial statements.
Financial Performance
The standalone financial results for FY26 showed a total income of ₹6,757.47 lakh, a significant increase from ₹2,776.08 lakh in the previous year. Total expenses for the year stood at ₹6,713.85 lakh. For the quarter ended March 31, 2026, the company reported a standalone net profit of ₹14.62 lakh. In contrast, the consolidated results for FY26 recorded a total income of ₹9,469.42 lakh against ₹3,289.31 lakh in the previous year, with total expenses rising to ₹9,918.16 lakh. The consolidated net loss for the year was ₹475.05 lakh, compared to a net profit of ₹75.07 lakh in FY25.
| Metric | Standalone FY26 (₹ in Lakh) | Standalone FY25 (₹ in Lakh) | Consolidated FY26 (₹ in Lakh) | Consolidated FY25 (₹ in Lakh) |
|---|---|---|---|---|
| Total Income | 6,757.47 | 2,776.08 | 9,469.42 | 3,289.31 |
| Total Expenses | 6,713.85 | 2,552.98 | 9,918.16 | 3,117.94 |
| Net Profit/(Loss) | 26.53 | 166.39 | (475.05) | 75.07 |
| Earnings Per Share (Basic) | 8.98 | 4.46 | (22.98) | 4.05 |
Segment Reporting and Investments
The company's operating business is organised into segments such as revenue from the sale of merchandise, software services, and other services. For the consolidated entity, revenue from hospital services and the sale of pharmacy products also contributed significantly. Geographically, the majority of the revenue was generated within India, amounting to ₹8,598.04 lakh for FY26, while revenue from outside India stood at ₹824.37 lakh.
During the year, the company invested ₹1,080 lakh by subscribing to 54,000 equity shares of Neuro and Spine Associates Private Limited, an associate company. Additionally, the company had allotted 1,87,500 equity shares via a preferential issue in January 2025, utilizing ₹1,386.85 lakh of the proceeds towards financing business opportunities and general corporate purposes by March 31, 2026.
Auditor's Report and Compliance
The audit reports were issued by PRSV & Co. LLP, Statutory Auditors. The auditors confirmed that the standalone and consolidated financial results give a true and fair view in conformity with the applicable accounting standards. The report also noted that the results for the quarter ended March 31, 2026, are the balancing figures between the audited full-year figures and the unaudited year-to-date figures up to December 31, 2025. The company confirmed compliance with Regulation 33 of the SEBI (LODR) Regulations, 2015.
Historical Stock Returns for Eyantra Ventures
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.64% | -3.33% | -0.68% | -25.26% | -27.86% | +3,303.76% |
What specific factors caused the consolidated entity to swing from a net profit in FY25 to a significant loss in FY26 despite the surge in total income?
How does the company plan to bridge the profitability gap between its standalone entity and its consolidated operations in the coming fiscal year?
What strategic value or synergies does the company expect to realize from its ₹1,080 lakh investment in Neuro and Spine Associates Private Limited?

































